- Home
- QURE vs PXED Comparison
QURE vs PXED Comparison
Compare QURE & PXED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | PXED |
|---|---|---|
| Founded | 1998 | 1976 |
| Country | Netherlands | United States |
| Employees | 248 | 3400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | QURE | PXED |
|---|---|---|
| Price | $27.85 | $30.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $45.00 | $44.29 |
| AVG Volume (30 Days) | ★ 1.9M | 76.2K |
| Earning Date | 05-05-2026 | 04-07-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $3.85 |
| Revenue Next Year | $200.43 | $4.49 |
| P/E Ratio | ★ N/A | $11.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $23.52 |
| 52 Week High | $71.50 | $38.19 |
Technical Indicators
Market Signals| Indicator | QURE | PXED |
|---|---|---|
| Relative Strength Index (RSI) | 68.49 | 52.42 |
| Support Level | $20.20 | $28.28 |
| Resistance Level | $29.03 | $30.85 |
| Average True Range (ATR) | 1.74 | 1.37 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 75.56 | 53.92 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About PXED Phoenix Education Partners Inc.
Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.